Lista de obras - Daniel Wright - Dominio Público Uruguay

'Massive' metformin overdose

artículo científico publicado en 2018

A Bayesian Dose-Individualization Method for Warfarin ⬇️

artículo científico publicado el 1 de enero de 2013

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins

artículo científico publicado en 2017

A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function.

artículo científico publicado en 2016

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments

artículo científico publicado en 2020

A factor VII-based method for the prediction of anticoagulant response to warfarin

artículo científico publicado en 2018

A general empirical model for renal drug handling in pharmacokinetic analyses

artículo científico publicado en 2017

A philosophical framework for pharmacy in the 21st century guided by ethical principles

artículo científico publicado en 2017

A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis

artículo científico publicado en 2016

A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

artículo científico publicado en 2014

Clinical decision-making: An essential skill for 21st century pharmacy practice

artículo científico publicado en 2018

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

artículo científico publicado en 2014

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C

artículo científico publicado en 2014

Dabigatran in patients with mechanical heart valves

artículo científico publicado en 2014

Dabigatran: rational dose individualisation and monitoring guidance is needed

artículo científico publicado el 29 de junio de 2012

Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models

artículo científico publicado en 2017

Evaluation of Assumptions Underpinning Pharmacometric Models

scientific article published on 05 August 2019

Evaluation of designs for renal drug studies based on the EMA and FDA guidelines for drugs that are predominantly secreted

artículo científico publicado en 2020

Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths).

artículo científico publicado en 2010

Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone

artículo científico publicado en 2013

Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout

artículo científico publicado en 2014

Individualising the dose of allopurinol in patients with gout

artículo científico publicado en 2017

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

artículo científico publicado en 2016

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

artículo científico publicado en 2011

Is the dose of dabigatran really more predictable than warfarin? ⬇️

artículo científico publicado el 1 de diciembre de 2013

Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters

artículo científico publicado en 2020

Learning more from the dabigatran concentrations in the RE-LY study

artículo científico publicado en 2014

Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

artículo científico publicado en 2014

Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance

scientific article published on 11 May 2020

Methods for Predicting Warfarin Dose Requirements.

artículo científico publicado en 2015

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

artículo científico publicado en 2020

Model-based Drug Dosing

2013 doctoral thesis by Daniel Frank Wright at University of Otago

Predicting allopurinol response in patients with gout

artículo científico publicado en 2015

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration

artículo científico publicado en 2019

Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'

artículo científico publicado en 2018

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

scientific article published on 12 November 2018

Science fiction has become reality: Best practice for future viral pandemics

artículo científico publicado en 2021

Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes

scientific article published on 09 August 2019

The 'apparent clearance' of free phenytoin in elderly vs. younger adults

artículo científico publicado en 2010

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool

artículo científico publicado en 2018

The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model.

artículo científico publicado en 2011

The intact nephron hypothesis as a model for renal drug handling

article

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

scientific article published on 09 December 2019

The pharmacokinetics of metformin in patients receiving intermittent haemodialysis

scientific article published on 14 February 2020

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

artículo científico publicado en 2013

The propagation of between-subject variability from dose to response

artículo científico publicado en 2020

Therapeutic decision-making in primary care pharmacy practice

scientific article published on 10 April 2020

The Association between Metformin Therapy and Lactic Acidosis

artículo científico publicado en 2019

Understanding the association between metformin plasma concentrations and lactate

artículo científico publicado en 2020

Understanding the process of clinical judgement for pharmacists when making clinical decisions

scientific article published on 10 August 2018

Understanding the time course of pharmacological effect: a PKPD approach

artículo científico publicado en 2011

What do we learn from repeated population analyses? ⬇️

artículo científico publicado el 1 de enero de 2015

Lista de obras de Daniel Wright

'Massive' metformin overdose

A Bayesian Dose-Individualization Method for Warfarin ⬇️

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins

A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function.

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments

A factor VII-based method for the prediction of anticoagulant response to warfarin

A general empirical model for renal drug handling in pharmacokinetic analyses

A philosophical framework for pharmacy in the 21st century guided by ethical principles

A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis

A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

Clinical decision-making: An essential skill for 21st century pharmacy practice

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C

Dabigatran in patients with mechanical heart valves

Dabigatran: rational dose individualisation and monitoring guidance is needed

Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models

Evaluation of Assumptions Underpinning Pharmacometric Models

Evaluation of designs for renal drug studies based on the EMA and FDA guidelines for drugs that are predominantly secreted

Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths).

Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone

Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout

Individualising the dose of allopurinol in patients with gout

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

Is the dose of dabigatran really more predictable than warfarin? ⬇️

Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters

Learning more from the dabigatran concentrations in the RE-LY study

Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance

Methods for Predicting Warfarin Dose Requirements.

Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy

Model-based Drug Dosing

Predicting allopurinol response in patients with gout

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration

Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

Science fiction has become reality: Best practice for future viral pandemics

Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes

The 'apparent clearance' of free phenytoin in elderly vs. younger adults

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool

The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model.

The intact nephron hypothesis as a model for renal drug handling

The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

The pharmacokinetics of metformin in patients receiving intermittent haemodialysis

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

The propagation of between-subject variability from dose to response

Therapeutic decision-making in primary care pharmacy practice

The Association between Metformin Therapy and Lactic Acidosis

Understanding the association between metformin plasma concentrations and lactate

Understanding the process of clinical judgement for pharmacists when making clinical decisions

Understanding the time course of pharmacological effect: a PKPD approach

What do we learn from repeated population analyses? ⬇️